Greetings!


SoCalBio Mast
SoCalBio Weekly Update

Past Weekly Updates

SoCalBio Partners

 

 

 

 

 

dwt

 

 

Los Angeles/Orange County Biotechnology Center 

SoCalBio Mast  

reedsmith  

   

SoCalBio Sponsored

EMBC2012

EMBC2012

SoCalBio members receive $200 discount per person on admission to the BioPharm America 2012. Click here to RSVP
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
Become a Member
Thanks to SoCalBio Media Partners
April 16, 2012




Editor: Ahmed Enany 
President & CEO
Southern California
Biomedical Council

enany@socalbio.org

www.socalbio.org

Botox

Botox: Going Strong After Ten Years and 11 Million Procedures Since Gaining FDA Approval

 

Pyott"When approved by the FDA in 2002, BOTOX Cosmetic changed the way that physicians could treat patients who were interested in improving the appearance of their vertical frown lines between the brows," said David E.I. Pyott (photo right), Chairman of the Board, President and CEO, Allergan, Inc. "BOTOX Cosmetic has become the number-one neuromodulator in the United States and the number of patients considering talking to their doctor about treatment has more than quadrupled to 5.8 million since 2002" ... Read more

Coming Tomorrow in Orange County

SoCalBio Executive Luncheon & Roundtable Discussion

 

Tracking, Trending and Comparing Adverse Events for Investigational and Commercial Medical Product

 

4/17/2012, 11:30 AM - 1:30 PM
Omnica (Irvine, CA)

 

RSVP Now

SoCalBio Networking Forum in the Inland Empire

 

Spotlight on Personalized Medicine

in Southern California

 

3/30/2012, 4PM - 7PM

Keck Graduate Institute (Claremont, CA)

RSVP Now

See Full SoCalBio Calendar of Events Open to the Public at: http://socalbio.org/calendar/calendar.htm
Honors
Congratulations to Winners of the 2012 SoCalBio Scholar Awards from Orange County
SoCalBio participated in the Orange County Science Fair held on April 10 to select 5 winners of its 2012 Scholar Awards. We are pleased to announce the following winners who were selected from participants representing high schools in the County: 

 

  • Jiho Park (University High School): "Modeling and Molecular Dynamics: Simulations of Membrane-bound Aromatase Reveal Insight Into Ligand Binding and Mechanism and Novel Druggable Sites"
  •  Kevin Lee (University High School)"Utility of the Spatial Peaks QR S-T Angle in Distinguishing Left Ventricular Hypertrophy From Athletic Heart Syndrome"
  •  Alex Jow (University High School)"ERK-related Synaptic Deficits in a Mouse Model of Autism: Potential Therapeutic Solutions to an Epidemic"
  •  Andrew Ninh (Fountain Valley High School)"Discovering the Distribution of Palindromic Sequences in the SMAD-4 Gene Using Large and Medium Deletion Mutations"
  • Dennis Shim (Woodbury High School)"Double-resistant Bacteria: Effect of Transforming Ampicillin and Kanamycin-resistant Plasmids on the Percentage of E. coli that is Double-resistant to Ampicillin and Kanamycin"


BioGENEiusThese students, along with winners of the 2012 SoCalBio Scholar Awards from Los Angeles, Ventura County, the Inland Empire, will compete for the opportunity to represent Southern California during the BioGENEius Challenge  organized by the Biotechnology Institute in conjunction with the BIO International Convention in Boston (MA) from June 18 to June 21. Out of the 20 SoCalBio Scholar Award winners, two nominees will be Selected by SoCalBio to compete for the BioGENEius Award. 

 

The International BioGENEius Challenge is the premier competition for high school students that recognizes outstanding research in biotechnology. The International BioGENEius Challenge promotes excellence and enables students to continue research in biotechnology and design an original independent research project. This competition is an intensive and valuable research experience for high school students.

Analysis

Cancer Vaccine Approaches: A Race For 

Dominance In The Field

 

NorrisAndrew Norris, PhD (photo right), of UCLA and the Pasadena-based BCN Biosciences reviews various company approaches in developing cancer Vacines. In his view, the Woodland Hills-based ImmunoCellular Therapeutics gets high marks for its developmental efforts because of its multiple antigen targeting approach ... Read article 

Public Policy

Big Pharma Not Big on Scrapping Health-care Reform

 

Big Pharma doesn't appear to be looking forward to having to go back to the drawing board on health-care reform if the landmark legislation is somehow struck down by an upcoming Supreme Court decision ... Read more

Click on image for more info
Rehab

USC's Stroke Rehab Robot Gently Prods

PatientsTo Do Exercises

 

medical RobotRather than merely being a speaking machine, the USC robot interacts almost like an early version of C-3PO, gently responding based on the person's mood. Not only will the robot give you a warm greeting, but during your rehab exercises it'll give you not-so-subtle feedback on your effort ("I may be a robot, but I am not blind") .... Read more  

New Financing

The Goleta-Based Inogen Secures $20 Million in Financing Led by Novo A/S

 

PyottInogen plans to use the new capital primarily to expand its sales and patient support resources, spread awareness among oxygen therapy users and also further solidify its market position by investing in R&D and the commercialization of innovative new products to improve the quality of life of oxygen users around the world .... Read more

Recent PMA Approvals

According to the FDA's Web Site, 10 PMAs Were Granted in January and February 2012 . 

 

Irvine Biomedical (Irvine) was the only company located within the SoCalBio geography encompassing Los Angeles, Orange County, The Inland Empire, and the Gold Coast that won a PMA approval for its Safire BLU cardiac ablation catheter

  • IB-CatheterApproved in January 2012,  the Irvine Biomedical's Therapy Cool Path Duo Ablation Catheter; Safire BLU Duo Ablation Catheter; and IBI 1500T-9 VI.6 Cardiac Ablation Generator  are intended for use in creating endocardial lesions during cardiac ablation procedures (mapping, stimulation and ablation) for the treatment of typical atrial flutter.
Coming in September

Save Money

SoCalBio Mast 

Companies utilizing the SoCalBio Group Purchasing Program enjoy significant savings on products and services procured through this program. Here are the actual savings generated from the SoCalBio-Office Depot program for office supplies and equipment:

 

Office Supplies Spend Range Under the SoCalBio-Office Depot Program
Average Savings Off List Price Under the SoCalBio-Office Depot Program
>$500k
$765,218
$250k - $500k
$319,731
$100k - $250k
$134,868
$50k - $100k
$82,801
$25k - $50k
$43,360
$10k - $25k 
$19,687
$1k - $10k
$4,876
<$1k
$491   
The savings represent average annual savings of the actual program participants in the BIO-VWR program. Results will vary based on individual company's Product Mix and Purchase Volume ...  Learn more 
SoCalBio Mast
Workforce of the Future

What will the Employees of a Scientific Company Look Like in 10 or 20 Years?

 

In a recent white paper, Alan Edwards, Vice President of Kelly Services, contends that the work of employees of scientific companies will probably be done in the cloud on a project-by-project basis. Their closest colleagues could be continents away. Many won't know what their offices look like, because they won't have them. After all, in the future it's about what you know, not where you sit. It is all going to be about free agency ... Click here to access the white paper.
Jobs Available
Inogen (Goleta)
Agensys (Santa Monica) 
Amgen (Thousand Oaks)
  • Amgen has 150 job openings in Thousand Oaks in research, marketing, information technology, quality, regulatory affairs and HR. Click here to access list
 Spectrum Pharmaceuticals (Irvine) 
C3 Jian (Inglewood)
Second Sight Medical Products (Sylmar) 

Bioness (Santa Clarita)

Alfred Mann Foundation for
Scientific Research (Santa Clarita)
About SoCalBio 
 
SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio